Objectives: We analysed the ability of Mycobacterium tuberculosis clinical isolates to penetrate and grow inside murine macrophages as a surrogate of fitness.
Introduction
In Mycobacterium tuberculosis, the agent of tuberculosis (TB), a loss of strain fitness due to changes produced by acquired drug resistance mutations has been described. 1 Initial studies on the virulence of these strains in animal models revealed lesser growth of the resistant strains compared with that of susceptible strains. 1 A turning point in fitness studies occurred when katG mutation at position 315 was associated with isoniazid resistance. This gene encodes catalase-peroxidase activity, which is key in preventing oxidative stress, and, thus, a mutation in this gene could affect the fitness of the mycobacteria. Isoniazid resistance mutations are observed mainly in the katG gene at position 315 and to a lesser extent in the intergenic zone mabA-inhA. 2 In vivo and in vitro models, such as epidemiological studies, have analysed the behaviour of resistant and susceptible strains, determining whether the acquisition of mutations in these strains has led to a cost in fitness, 3, 4 albeit with no clear conclusions being drawn.
In the present study, we analysed the ability of M. tuberculosis clinical isolates to penetrate and grow inside murine macrophages as a surrogate of fitness.
Materials and methods
Isolates, MICs and molecular resistance analysis The MIC of isoniazid for each isolate was determined using the proportions method in Middlebrook 7H11 medium incubated for 21 days at serial 2-fold concentrations ranging from 0.1 to 102.4 mg/L.
The ribosome binding site (RBS) region of the inhA gene (GenBank U02492.1), the entire katG gene (GenBank X68081.1) and the rifampicin resistance-determining region of the rpoB gene (GenBank L27989.1) were sequenced using primers described previously. 5 Macrophage culture and M. tuberculosis inoculum preparation J774.2 cell line murine macrophages (Sigma 85011428) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with L-glutamine, 4.5 g/L glucose (Lonza, Switzerland), 10% heat-inactivated fetal calf serum (Lonza), and a 100 U/mL penicillin and streptomycin mixture (Sigma), at 378C in 5% CO 2 until exponential growth was achieved.
The isolates were grown in 7H9 MGIT medium (Becton Dickinson, MD, USA), supplemented with 0.25% Tween 80 (Merck, Germany) to avoid clump formation. When the MGIT was positive, the sample was centrifuged at 1174 g for 20 min, discarding the supernatant. Then, after adding 5 mm glass beads, the tube was shaken for 45 s and sonicated for 1 min. Lastly, clumps were disaggregated by 14 passages through a syringe needle (20G 1 ′′ 0.9×25 mm) and 4 passages through an insulin needle (27G 1 2 ′′ 0.4×12 mm). The inoculum was adjusted to a turbidity equivalent to that of a 0.5 McFarland standard, making dilutions up to 100000 cfu/mL. Fifty mL of this inoculum was plated on Middlebrook 7H11 medium and incubated at 378C in 5% CO 2 for 21 days. Quantitative counts were made thereafter.
Infection protocol
The ability of infection of the different M. tuberculosis clinical isolates studied was determined using the mycobacterial penetration index (MPI) and the mycobacterial growth ratio (MGR). The MPI was defined as the percentage of mycobacterial cells penetrating inside the macrophages, and the MGR was defined as the intracellular growth index of the mycobacterial cells during the 6 day protocol.
Determination of MPI
Volumes of 1 mL of supplemented antibiotic-free DMEM containing 50000 murine macrophages were seeded in 24-well plates and incubated at 378C in 5% CO 2 . Each isolate studied was tested in duplicate. The macrophages were incubated for 3 h with M. tuberculosis at a multiplicity of infection of 1:1. This point was considered day 0. The macrophages were washed three times with DMEM and lysis was performed by adding 0.5% NP40 detergent (Roche, Switzerland). After two washes, the cell lysate was seeded onto Middlebrook 7H11 plates and incubated at 378C in 5% CO 2 for 3 weeks. Quantitative counts were made and the MPI was calculated as the proportion of cfu isolated in cell lysates on day 0 with respect to the cfu of the inoculum used.
Determination of MGR
A duplicate set of infected cells remained in incubation during the 6 day protocol. The medium was renewed after 1, 4 and 5 days of infection. The MGR was calculated as the ratio between the cfu of cell lysates on day 6 and the cfu of cell lysates on day 0.
Statistical analysis
The MPI and MGR of the different isolate groups were analysed using the Kruskal-Wallis test for more than two group comparisons. If the Kruskal-Wallis test showed significance, the Mann-Whitney U-test for two group comparisons was performed. Bonferroni adjustments for multiple comparisons among groups were used in this case. Statistical analyses were performed using SPSS 16, v02. Table 1 shows the molecular mechanisms of resistance and the MIC of isoniazid for the 35 drug-resistant isolates studied. Neither Isolates resistant to isoniazid without a known katG or inhA mutation.
Results
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the MPI nor the MGR significantly differed according to the MIC ranges for the isolates studied.
MPI according to the resistance pattern
No significant difference was observed on comparing the MPI of the isolates, according to four categories: susceptible; isoniazid resistant; rifampicin resistant; and multidrug resistant (MDR). A trend to significantly lower values was observed on comparing the MPI of the MDR isolates with that of the drug-susceptible and the isoniazid-resistant isolates (P ¼ 0.042 and P¼ 0.036, respectively).
MPI according to the mutations associated with resistance
A lower MPI was found in the resistant isolates with a mutation in the katG gene compared with those resistant without this mutation (P ¼ 0.009), although no significant differences were observed on comparison with drug-susceptible isolates (Figure 1a) .
MGR according to the resistance pattern
On comparing the above-mentioned categories, the MGR was significantly lower in the MDR isolates than in the drugsusceptible isolates (P ¼ 0.012). The isoniazid-resistant isolates showed a trend to having a significantly lower MGR than drugsusceptible isolates (P ¼ 0.074). Isolates resistant to only rifampicin did not significantly differ from drug-susceptible isolates.
MGR according to the mutations associated with resistance
A significantly lower MGR was found in the 21 isolates with a katG gene mutation compared with drug-susceptible isolates (P ¼ 0.013). No significant difference was found when drugsusceptible isolates were compared with those without a katG gene mutation (Figure 1b) . Furthermore, no significant difference was observed on comparing the 13 isolates with only a katG gene mutation and 8 isolates with mutations in the katG and rpoB genes with the drug-susceptible isolates (P ¼ 0.030 and P ¼ 0.041, respectively).
Discussion
The most important result of the present study is that isoniazid-resistant isolates with a katG gene mutation at position 315 and MDR isolates showed significantly lower growth in a murine macrophage model compared with drug-susceptible isolates.
The study of the molecular epidemiology of M. tuberculosis isolates is an excellent method to analyse TB transmission patterns by analysis of clusters and secondary cases and to indirectly study the fitness and virulence of clinical isolates. In this context, a significant number of isolates 6 -8 reported in different studies are worthy of comment. Burgos et al. 6 detected fewer secondary cases from resistant isolates (MDR and only isoniazid resistant) than from susceptible isolates. In contrast, van Doorn et al. 7 found that isolates with a katG gene mutation at position 315 were clustered as frequently as those susceptible to isoniazid. Likewise, Gagneux et al. 8 indicated that isolates with the same mutation had as many secondary cases as those with a mutation in the inhA gene and suggested the same hypothesis as van Doorn et al., 7 despite not comparing these isolates with drug-susceptible isolates.
Although in vitro models of macrophages from cell cultures provide an excellent opportunity to directly study the fitness of M. tuberculosis isolates, 9 the literature is limited, 4 making it difficult to draw clear conclusions. To our knowledge, the present study has analysed the capacity of penetration and multiplication of the largest number of susceptible and drug-resistant clinical isolates (10 and 35, respectively) according to their resistance pattern as well as their associated mutations reported to Fitness of M. tuberculosis drug-resistant isolates date. Similar to the previously mentioned epidemiology studies, 6 we observed that the fitness of MDR isolates decreased compared with that of drug-susceptible isolates. We also observed an alteration in the fitness of the isoniazid-resistant isolates with mutation in the katG gene at position 315, in contrast to the previously reported results. 7, 8 This fitness alteration in isoniazid-resistant isolates with a mutation in the katG gene could be explained by some loss of catalase -peroxidase function.
2 Discordance with epidemiological studies may be explained by the greater difficulty in detecting impaired fitness with indirect methods. In this sense, some aspects of molecular epidemiological analysis could contribute to increase the specificity of further studies on the epidemiological links among isolates from clusters, such as the use of secondary markers and contact tracing to determine whether patients belong to the same cluster or are not linked at all.
Recently, it has been reported that the dynamics of TB transmission may also be affected by the bacterial genetic background of M. tuberculosis, which may influence the clinical localization, diagnostic aspects and the virulence of the isolates. 10 Thus, future studies on the fitness of M. tuberculosis should consider these aspects.
In conclusion, isoniazid-resistant and MDR isolates with a katG gene mutation showed a decrease in their multiplication inside murine macrophages, suggesting a lower fitness of TB with these resistance patterns.
